Effects of Olanzapine on Metabolism in Schizophrenia
Author Information
Author(s): Jin Weifeng, Chen Shuzi, Li Dan, Chen Qing, Zhu Mengyuan, Wang Mengxia, Fu Xiaomei, Lin Ping
Primary Institution: Shanghai Mental Health Center, China
Hypothesis
What are the metabolic changes and clinical outcomes of patients with schizophrenia treated with olanzapine?
Conclusion
Adjusting the dosage of olanzapine based on blood concentration can maximize efficacy while minimizing metabolic side effects.
Supporting Evidence
- Patients receiving olanzapine had significant weight gain.
- Clinical response improved with higher plasma concentrations of olanzapine.
- Weight gain was rapid in the first few weeks of treatment.
- Changes in cholesterol levels were not significant during treatment.
- Individual responses to olanzapine dosage varied among patients.
Takeaway
This study found that olanzapine can help people with schizophrenia feel better, but it might also make them gain weight.
Methodology
A systematic review and meta-analysis of clinical trials using databases like PubMed and Cochrane Library to assess metabolic changes and clinical responses.
Potential Biases
Some included studies had a lower quality, particularly in random sequence generation and allocation concealment.
Limitations
The study included a limited number of studies with varying quality, and the heterogeneity of the population may affect outcomes.
Participant Demographics
1839 participants, 1058 male and 781 female, aged 15 to 55 years.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 0.06–0.44
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website